Company / Current Liabilities per Share
Whitehawk Therapeutics, Inc. Current Liabilities per Share History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities per Share
$0.59
FY2025
5-year range
$0.59 / $7.53
FY2021-FY2025
Trend
-15.4%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Current Liabilities per Share has declined for 3 consecutive years, from $7.53 in FY2022 to $0.59 in FY2025.
Based on SEC 10-K filings.
0.59 in FY2025 with a 5-year CAGR of +66.5%.
Improved from $1.08 to $0.59 over the past 2 years.
Current Liabilities per Share over time
Growth rates
- 3-Year CAGR
- -57.3%
- 5-Year CAGR
- +66.5%
- 10-Year CAGR
- -
Key checks
Key Insights
- Whitehawk Therapeutics, Inc.'s current liabilities per share has declined for 3 consecutive years.
- In FY2025, current liabilities per share decreased 15.4% year-over-year.
- Peak current liabilities per share was recorded in FY2022.
- Lowest current liabilities per share in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score -0.35 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Liabilities per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.59 | -15.4% |
| FY2024 | $0.70 | -35.6% |
| FY2023 | $1.08 | -85.7% |
| FY2022 | $7.53 | +25.4% |
| FY2021 | $6.01 | +12961.3% |
| FY2020 | $0.05 | -44.0% |
| FY2019 | $0.08 | -59.3% |
| FY2018 | $0.20 | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026